Biotech Values

[maverick_1]

EpiPen Overnight Reversal due to Hilliary's Tweet:
Mylan takes Clinton's comments to heart, will cover up to $300 of out-of-pocket costs for EpiPen; shares up 3% premarket
Aug 25 2016, 07:46 ET | About: Mylan Inc (MYL) | By: Douglas W. House, SA News Editor Contact this editor with comments or a news tip
Democratic Presidential candidate Hillary Clinton's bully pulpit directed at Mylan N.V. (NASDAQ:MYL) over the high price of EpiPen (epinephrine injection, USP) Auto-Injector worked.The company announces a more generous patient assistance program to reduce out-of-pocket costs as much as 50% off the list price via a savings card that will cover up to $300 of the cost of the EpiPen 2-Pak. In addition, Mylan is doubling the eligibility for its patient assistance program to 400% of the federal poverty level which will eliminate out-of-pocket costs for the uninsured and under-insured. A family of four with an annual income of up to $97,200, for example, will pay nothing for their EpiPen Auto-Injector.Mylan will continue its EpiPen4Schools program, which was launched in August 2012. It has provided more than 700K free EpiPen Auto-Injectors and educational resources to more than 65K schools across the country.To further reduce patient costs, the company is opening a pathway whereby patients can order EpiPen directly from the company. All programs apply to EpiPen Jr as well.CEO Heather Bresch says, "We have been a long-term committed partner to the allergy community and are taking immediate action to help insure that everyone who needs EpiPen Auto-Injector gets one. We recognize the significant burden on patients from continued rising insurance premiums and being forced increasingly to pay the full list price for medicines at the pharmacy counter. Patients deserve increased price transparency and affordable care, particularly as the system shifts significant costs to them. However, price is only one part of the problem that we are addressing with today's actions. All involved must also take steps to help meaningfully address the U.S. healthcare crisis, and we are committed to do our part to drive change in collaboration with policymakers, payors, patients and healthcare professionals."MYL is up 3% premarket on increased volume.
http://seekingalpha.com/news/3205321-mylan-takes-clintons-comments-heart-will-cover-300-pocket-costs-epipen-shares-3-percent